It’s a short and dramatic plunge for Orexigen Therapeutics, Inc. (NASDAQ:OREX).
Orexigen Therapeutics, Inc. (NASDAQ:OREX) On May 12, 2015 Shares of Orexigen tanked by 13% after the company reported that the cardiovascular outcome study had …
NASDAQ: CHRS– We recommended investors buy Coherus a few weeks ago under the IPO price when it was trading around $13.10.